MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynamics

Biomarkers and effective therapeutic agents to improve the dismal prognosis of pancreatic ductal adenocarcinoma (PDAC) are urgently required. We aimed to analyze the prognostic value and mechanistic action of miR-93 in PDAC. Correlation of miR-93 tumor levels from 83 PDAC patients and overall surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Vila-Navarro, Elena, Fernandez-Castañer, Elena, Rovira-Rigau, Maria, Raimondi, Giulia, Vila-Casadesus, Maria, Lozano, Juan Jose, Soubeyran, Philippe, Iovanna, Juan, Castells, Antoni, Fillat, Cristina, Gironella, Meritxell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198506/
https://www.ncbi.nlm.nih.gov/pubmed/32366853
http://dx.doi.org/10.1038/s41389-020-0227-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198506/
https://www.ncbi.nlm.nih.gov/pubmed/32366853
http://dx.doi.org/10.1038/s41389-020-0227-y

Ejemplares similares